Therapeutic Partnerships
Leveraging HD-DoE® for Cell Therapy Development
Trailhead Biosystems develops cell differentiation protocols using our High-Dimensional Design-of-Experiments (HD-DoE®) platform. This systematic approach allows us to precisely map how multiple inputs ultimately drive cell fate decisions.
Rather than optimizing conditions one variable at a time, HD-DoE enables Trailhead to simultaneously explore complex parameter spaces to best define differentiation processes with unprecedented accuracy. This results in tight control over cell identity, purity, and yield, along with enabling improved reproducibility across runs and at scale.
The benefits of HD-DoE are the same attributes that are required to move a project from exploratory biology to defined, scalable processes suitable for therapeutic development.
Flexible Partnering
We selectively engage with partners to extend these capabilities into therapeutic contexts, focusing on protocol definition and process development.
At Trailhead, our role is focused on generating well-characterized differentiation systems that can be transferred and built upon. This role emphasis then enables our partners to lead downstream clinical development and manufacturing more effectively.
Trailhead Engagement Points:
- Protocol licensing
- Technology transfer
- Early-stage co-development
- Research collaborations